Skip to main content
Log in

Alcoholic cardiomyopathy

  • Therapeutic Management Of Cardiomyopathy
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Clinical observations over the past two decades have pointed to the relationship between heart disease and alcohol abuse, usually without evident malnutrition or cirrhosis. While the prevalence of heart failure in the alcoholic population is now known, subclinical abnormalities of left ventricular function in noncardiac alcoholics who were normotensive have a high prevalence with or without some degree of ventricular hypertrophy by echocardiogram. This is frequently a diastolic rather than systolic abnormality. Congestive cardiomyopathy is not infrequently associated with high diastolic arterial blood pressures. Intoxication itself may contribute to blood pressure elevation. Angina pectoris in the absence of significant coronary disease is another presentation. Although the history may not be readily obtained, the major diagnostic feature in this entity is the history of ethanol ingestion in intoxicating amounts for at least 10 years, often marked by periods of spree drinking. While the course of congestive cardiomyopathy may be progressively downhill in individuals who continue to be actively alcoholic after the onset of heart failure, in one series one third of the patients became abstinent. These patients had a 4 year mortality that was persistently one-sixth of the alcoholic group. Management of heart failure is traditional in these patients. Atrial arrhythmias have been shown to occur during the early ethanol withdrawal phase in patients without other clinical evidence of heart disease. Sudden death in a segment of the alcoholic population is considered arrhythmia related and is commonly associated with cigarette use. Identification of the addicted individual is the essential element to management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Regan TJ. Alcoholic cardiomyopathy. In: Zipes DP, Rowlands DJ, eds.Progress in Cardiology. Philadelphia: Lea and Febiger, 1989:129.

    Google Scholar 

  2. Schwartz F, Mall G, Zebe H, et al. Determinations of survival in patients with congestive cardiomyopathy: Quantitative morphological findings and left ventricular hemodynamics.Circulation 1984;70:923–928.

    PubMed  Google Scholar 

  3. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients.Am J Cardiol 1987;60:1340–1355.

    PubMed  Google Scholar 

  4. Cerqueira MD, Harp GD, Ritchie JL, Stratton JR, Walker RD. Rarity of preclinical alcoholic cardiomyopathy in chronic alcoholics less than 40 years of age.Am J Cardiol 1991;67:183–187.

    PubMed  Google Scholar 

  5. Kupari M, Koskinen P, Suokas A, Ventila M. Left ventricular filling impairment in asymptomatic chronic alcoholics.Am J Cardiol 1990;66:1473–1477.

    PubMed  Google Scholar 

  6. Thomas G, Haider B, Oldewurtel HA, Lyons MM, Yeh C, Regan TJ. Progression of myocardial abnormalities in experimental alcoholism.Am J Cardiol 1980;46:233–241.

    PubMed  Google Scholar 

  7. Urbano-Marquez A, Estruch R, Navarro-Lopez G, et al. The effects of alcoholism on skeletal and cardiac muscle.N Engl J Med 1989;320:409.

    PubMed  Google Scholar 

  8. Regan TJ, Levinson GE, Oldewurtel HA, et al. Ventricular function in noncardiacs with alcoholic fatty liver: Role of ethanol in the production of cardiomyopathy.J Clin Invest 1969;48:397–407.

    PubMed  Google Scholar 

  9. Ahmed SS, Levinson GE, Fiore JJ, Regan TJ. Spectrum of heart muscle abnormalities related to alcoholism.Clin Cardiol 1980;3:335–341.

    PubMed  Google Scholar 

  10. Ahmed SS, Howard M, ten Hove W, et al. Cardiac function in alcoholics with cirrhosis: Absence of overt cardiomyopathy—myth or fact?J Am Coll Cardiol 1984;3:696.

    PubMed  Google Scholar 

  11. Saunders JB, Bannan LT, Beevers DG, et al. Alcohol and hypertension.Lancet 1982;1:401–402.

    Google Scholar 

  12. Ettinger PO, Wu CF, DeLaCruz C Jr, et al. Arrhythmias and the “holiday heart”: Alcohol-associated cardiac rhythm disorders.Am Heart J 1978;95:555.

    PubMed  Google Scholar 

  13. Lowenstein SR, Gabow PA, Cramer J, et al. The role of alcohol in new onset atrial fibrillation.Arch Intern Med 1983;143:1882–1885.

    PubMed  Google Scholar 

  14. Kramer K, Culler L, Fischer R. The increasing mortality attributed to cirrhosis and fatty liver in Baltimore (1957–1966).Ann Intern Med 1968;69:273–282.

    PubMed  Google Scholar 

  15. Randall B. Sudden death and hepatic fatty metamorphosis: A North Carolina study.JAMA 1980;243:1723.

    PubMed  Google Scholar 

  16. Rosengren A, Wilhelmsen L, Wedel H. Separate and combined effects of smoking and alcohol abuse in middle-aged men.Acta Med Scand 1988;223:111–118.

    PubMed  Google Scholar 

  17. Vikhert, AM, Tsiplenkova VG, Cherpachenka NM. Alcoholic cardiomyopathy and sudden cardiac death.J Am Coll Cardiol 1986;8:3A.

    Google Scholar 

  18. Taasan VC, Block AJ, Boysen PG, et al. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men.Am J Med 1981;71:240.

    PubMed  Google Scholar 

  19. Molgaard H, Kristensen BO, Baandrup. Importance of abstention from alcohol in alcoholic heart disease.Int J Cardiol 1990;26:373–375.

    PubMed  Google Scholar 

  20. Kinney EL, Wright RJ, Caldwell JW. Risk factors in alcoholic cardiomyopathy.Angiology 1989;40:270.

    PubMed  Google Scholar 

  21. Demakis TG, Proskey A, Rahimtoola SH, et al. The natural course of alcoholic cardiomyopathy.Ann Intern Med 1974;80:293–297.

    PubMed  Google Scholar 

  22. McDonald CD, Burch GE, Walsh JJ. Alcoholic cardiomyopathy managed with prolonged bed rest.Ann Intern Med 1971;74:681–691.

    PubMed  Google Scholar 

  23. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enapril survival study (Consensus).N Engl J Med 1987;316:1429–1435.

    Google Scholar 

  24. The SOLVD investigators. Effect of the angiotensin converting enzyme inhibitor enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure.N Engl J Med 1991;325:392.

    Google Scholar 

  25. Francis GS, Johnson TH, Ziesche S, Berg M, Boosalis P, Cohn JN. Marked spontaneous improvement in ejection fraction in patients with congestive heart failure.Am J Med 1990;89:303–307.

    PubMed  Google Scholar 

  26. Thomas BA, Regan TJ. Interactions between alcohol and cardiovascular medications.Alcohol Health Res World 1990;14:333–339.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fabrizio, L., Regan, T.J. Alcoholic cardiomyopathy. Cardiovasc Drug Ther 8, 89–94 (1994). https://doi.org/10.1007/BF00877094

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877094

Key Words

Navigation